Osphena vs Intrarosa: Which Fits You for Painful Sex or Vaginal Dryness After Menopause?
By The HRT Index Editorial Team · Last verified: June 2026.Educational only — not medical advice, and not reviewed by a clinician. If you buy through a provider we link to, we may earn a commission. It never changes what we verify or what we recommend.
Osphena vs Intrarosa comes down to three things: how you want to take it, your health history, and what you’ll actually pay. Both are FDA-approved prescriptions for painful sex after menopause, and neither one is estrogen. Osphena is a once-a-day pill (also approved for vaginal dryness) that carries a boxed safety warning. Intrarosa is a nightly vaginal insert with noboxed warning. Neither is “better” for everyone.
And if you’re paying cash, the price gap between them is dramatic in a way most comparison pages skip entirely — which is exactly why we’re leading with it.
Best for you to ask about — or not
| Option | A good fit to ask about if… | Not your first online-care step if… |
|---|---|---|
| Osphena (a pill) | You’d rather take a daily pill than use anything vaginally, and your problem is painful sex and/or vaginal dryness. | You have unexplained vaginal bleeding, a history of blood clots, stroke, or heart attack, an estrogen-sensitive cancer, or severe liver disease. |
| Intrarosa (a vaginal insert) | You’d rather treat the area directly, you mostly want help with painful sex, and you don’t mind a nightly insert. | You have unexplained vaginal bleeding, or a breast-cancer history that needs your doctor and oncologist to weigh in first. |
| Low-dose vaginal estrogen (the third option) | Cost matters, you have no reason to avoid estrogen, and you want the standard first-line treatment — often the cheapest because several forms have generics. | You specifically can’t or don’t want to use any estrogen — then Osphena or Intrarosa may make more sense. |
The right next step isn’t the same for every woman.
It depends on your symptoms, your age, how you’d prefer to take treatment, your risk history, your insurance, and your state. Some situations should start with an in-person clinician, not online. Use The HRT Index’s Find My HRT Path tool to match your situation to the right starting point in about 90 seconds.
Find My HRT Path →Osphena vs Intrarosa at a glance
Both Osphena (ospemifene) and Intrarosa (prasterone) are FDA-approved prescriptions for moderate-to-severe painful sex caused by menopause. The biggest differences are how you take them, what’s on their safety labels, the side effects they cause, and the price you pay. Last verified: June 2026. Prices change by pharmacy, plan, and coupon — confirm yours at checkout.
| What you’re comparing | Osphena (ospemifene) | Intrarosa (prasterone) |
|---|---|---|
| What it is | A pill. A SERM (selective estrogen receptor modulator — acts like estrogen in some tissues and blocks it in others). Marketed as “non-hormonal” because the drug itself isn’t a hormone, but it has estrogen-like effects in some places. | A vaginal insert. Made from prasterone, a lab-made form of DHEA (a natural hormone). Your body turns it into estrogens and androgens in the vaginal tissue. |
| Is it estrogen? | No — but it acts like estrogen in some tissues, including the lining of the uterus. | No — but it’s a hormone your body converts into estrogen (and androgen) locally. |
| How you take it | One 60 mg tablet once a day, with food. | One 6.5 mg insert every night at bedtime, with an applicator. |
| FDA-approved to treat | Moderate-to-severe painful sex AND vaginal dryness from menopause. | Moderate-to-severe painful sex from menopause. |
| Boxed warning | Yes — for endometrial (uterine) cancer and heart/blood-vessel risks. | No boxed warning. |
| Breast-cancer history | Label says not to use with known, suspected, or past breast cancer. | Label warns estrogen is a metabolite of prasterone and estrogen medicines aren’t for women with a breast-cancer history; not studied in that group. |
| Other big “stop” flags | Unexplained vaginal bleeding; history of blood clots (DVT/PE), stroke, or heart attack; severe liver problems; pregnancy. | Unexplained vaginal bleeding (the formal contraindication). |
| Most common side effect | Hot flashes (it works through your whole body). | Vaginal discharge / leakage; with longer use, changes on a Pap smear. |
| Generic available? | No — brand only. | No — brand only. |
| Cash price (no insurance) | As low as ~$85 for 30 tablets or ~$190 for 90 through the maker’s own programs. | About $290–$420/month; around $320 with a discount card. |
| Price with commercial insurance + maker’s card | As low as ~$35–$45/month. | As low as ~$35/month. |
| Best for | Wanting a pill, having dryness and pain, or paying cash. | Keeping treatment local, pain-focused symptoms, and having commercial insurance. |
Sources: FDA/DailyMed labels; osphena.com/savings; us.intrarosa.com; GoodRx; SingleCare; Drugs.com — verified June 2026.
Is Osphena or Intrarosa safe for me?
Both labels share one firm rule:if you have vaginal bleeding that a doctor hasn’t explained yet, don’t try to treat yourself online. Bleeding after menopause can have causes that need an exam first. Undiagnosed abnormal genital bleeding is the formal contraindication on both labels.
Osphena carries a “boxed warning” — the strongest warning the FDA puts on a label. For Osphena, it covers two things: a risk of cancer in the lining of the uterus (the endometrium), and heart and blood-vessel risks like blood clots and stroke. Osphena’s label also says it should not be used if you have a history of blood clots (DVT or PE), stroke, heart attack, an estrogen-sensitive cancer, severe liver problems, or during pregnancy.
Intrarosa has no boxed warning.Its key safety note is about breast cancer: because your body turns prasterone into estrogen, and estrogen medicines aren’t meant for women who have or have had breast cancer, the label says Intrarosa shouldn’t be used by women with a breast-cancer history — and it hasn’t been studied in that group.
Quick gut-check: who should start in person, not online
| If you have… | Why it matters | Safer first step |
|---|---|---|
| Unexplained vaginal or genital bleeding | The formal contraindication on both labels | In-person clinician first |
| A history of blood clots, stroke, or heart attack | Osphena’s label says not to use it | Clinician review before Osphena |
| An estrogen-sensitive cancer | Osphena’s label says not to use it | Specialist-guided decision |
| A breast-cancer history | Intrarosa’s label says estrogen medicines aren’t for you; Osphena needs careful review | You + clinician + oncologist |
| Severe liver problems | Osphena’s label says not to use it | Clinician review; likely avoid Osphena |
| Burning, odd discharge, or pain that might be an infection or a skin condition | Not all pain “down there” is menopause | Get the cause checked first |
If you read that table and felt a flicker of “wait, that might be me” — good. That’s exactly the moment to slow down.
Check my starting point with Find My HRT Path →Which is better for painful sex after menopause?
Painful sex after menopause has a medical name: dyspareunia. It’s part of a bigger picture doctors call GSM (genitourinary syndrome of menopause)— the dryness, thinning, and irritation that happen when estrogen drops. Up to 60% of women after menopause deal with some version of it, and most never get treated, often out of embarrassment.
Both have solid evidence that they beat a placebo at reducing pain and improving vaginal tissue. But when Canada’s drug-review agency, CADTH, looked at the bigger studies, it found no evidence that either one provides added benefit over other available treatments — and there’s no trial that puts Osphena and Intrarosa head to head. The choice isn’t about which is “stronger.” It’s about which fits you.
And the flip side is real too: because Osphena is a daily pill, it’s the only option of the two you can use without inserting anything. For women who can’t or won’t use a vaginal product — because of arthritis, discomfort, or just preference — that matters a lot. And it’s the only one of the two also approved for vaginal dryness, not just pain. If a nightly insert is the dealbreaker, a less-frequent vaginal estrogen tablet or ring may be worth asking about; if anything vaginal is the dealbreaker, Osphena is the route that avoids vaginal application entirely.
Match your situation
| If your painful sex comes with… | A reasonable thing to ask about | Why |
|---|---|---|
| A lot of dryness too | Osphena, or vaginal estrogen | Osphena is labeled for dryness; vaginal estrogen treats both |
| A strong “I don’t want anything vaginal” feeling | Osphena | It’s a pill |
| A preference to keep treatment local | Intrarosa, or vaginal estrogen | Both act mainly in one spot |
| Tightness, burning, recurrent infections, or any bleeding | See a clinician in person first | It may not be simple GSM |
Which is better for vaginal dryness?
Osphena is FDA-approved for vaginal dryness and painful sex. Intrarosa is FDA-approved for painful sex.That doesn’t mean Intrarosa does nothing for dryness — by improving the vaginal tissue, it often helps dryness too. But if dryness is your main complaint and you want the medication whose label matches that exactly, Osphena fits more cleanly. So does vaginal estrogen, which we’ll get to.
What does Osphena vs Intrarosa cost in 2026?
Neither drug has a generic yet, so the sticker prices are high. But what you actually pay depends entirely on your insurance — and here’s where the two split in a way that surprises people.
The savings-card gap (the thing nobody tells you)
| Your situation | Osphena | Intrarosa |
|---|---|---|
| Commercial insurance + maker’s card | As low as $35 for 30 tablets (mail program) or $45 for 30 (retail card) | As low as $35 for a 28-day supply |
| Uninsured / paying cash | As low as $85 for 30 tablets or $190 for 90 (about $63/month) through the maker’s own programs | About $290–$420/month; around $320 with a GoodRx or SingleCare coupon |
| Medicare (paying cash or using a coupon) | Same maker programs: about $85 for 30 or $190 for 90 | A separate Medicare coupon, as low as $85 for a 28-day supply |
Sources: osphena.com/savings; us.intrarosa.com; GoodRx; SingleCare; Drugs.com — verified June 2026.
If you have commercial insurance, the two cost about the same — roughly $35 a month with a card. But if you’re uninsured, Osphena is dramatically cheaper— about $85 a month (or $190 for a 90-day supply) through its own programs, versus around $320 a month for Intrarosa. That’s because Osphena’s savings programs apply to cash payers, while Intrarosa’s manufacturer cards are for commercially insured or Medicare patients only. For a lot of women, that single fact — not the medicine itself — decides what’s affordable.
- A drug-discount card (like GoodRx) usually can’t be combined with a manufacturer card — use whichever is cheaper for you.
- Manufacturer cards exclude government insurance like Medicaid, TRICARE, and the VA in most cases.
- Every price here is a starting point. Call your pharmacy and confirm your real number before you fill anything.
Bottom line before you pay: don’t choose from the sticker price. Ask what this will cost at your pharmacy — and whether a cheaper FDA-approved option fits your symptoms.
Is there a cheaper or better option than Osphena or Intrarosa?
For most women with GSM, the standard first step isn’t either of these two drugs — it’s low-dose vaginal estrogen. It treats both dryness and pain, several forms have generics(so it’s often the cheapest path — generic estradiol tablets often run roughly $50–$120 a month, far below brand-only Osphena or Intrarosa), and studies consistently show it puts very little estrogen into your bloodstream. Coverage varies by plan, so check yours.
The same Canadian drug review (CADTH) found that both Osphena and Intrarosa cost more than vaginal estrogen, and recommended covering them only if they don’t cost more than the cheapest vaginal estrogen option. Major menopause and women’s-health centers point to low-dose vaginal estrogen as a first-line GSM treatment too.
So why would anyone choose Osphena or Intrarosa instead? Three honest reasons:
- You want to avoid estrogen. Many women feel nervous about estrogen, or prefer a “non-estrogen” label. Osphena and Intrarosa fit that wish (with the breast-cancer cautions above).
- You want a pill. Only Osphena gives you that.
- Vaginal estrogen didn’t work for you, or you couldn’t tolerate it. Then a different mechanism is worth trying.
How do Osphena and Intrarosa side effects compare day to day?
Think of it as a trade between whole-body effects and local mess.
Osphena (the pill) works through your whole body, so its side effects do too. The most common is hot flashes. Its label also lists vaginal discharge, muscle spasms, headache, heavy sweating, heavier vaginal bleeding, and night sweats among common reactions. Because it acts on the uterine lining, any new vaginal bleeding should be reported right away.
Intrarosa (the insert) works mostly in one place, so its most common side effect is vaginal discharge — basically leakage, since you insert it at night and some comes back out. Its label also notes changes on a Pap smear with longer use (often the kind your clinician simply monitors). Two practical tips that come up again and again in reviews: insert it as high as you can right before bed, and keep a panty liner handy.
A lower-warning label doesn’t mean “risk-free.”It means the labeled risks are different. Your personal history — clots, cancer, liver, bleeding — decides which risks actually apply to you.
Which one is easier to use every day?
| Daily-life question | Osphena | Intrarosa |
|---|---|---|
| When you take it | Once a day | Every night |
| With food? | Yes | Doesn’t matter |
| Anything vaginal? | No | Yes |
| Mess or discharge? | Less of this | Discharge/leakage is common |
| Travel-friendly? | A pill bottle | Inserts + applicators |
| Timing around sex | No vaginal step to plan around | Nightly insert can feel inconvenient |
Osphena: “I want a pill, and my clinician agrees the safety profile fits me.”
Intrarosa: “I want a local option, and I can live with a nightly insert and some discharge.”
Does Osphena or Intrarosa actually work? What real patients say
| Source (painful sex / dyspareunia) | Rating | Reviews | Positive | Negative |
|---|---|---|---|---|
| Osphena — Drugs.com | 6.7 / 10 | 25 | 56% | 28% |
| Intrarosa — Drugs.com | 5.2 / 10 | 112 | 38% | 42% |
Source: Drugs.com patient reviews, verified June 2026. Review data is patient-reported, not clinical evidence.
The positive reviews: one Osphena user wrote that it “has given me back my sex life” after just a few days. One Intrarosa user said she feels “like the sensual woman I was before,” and a long-time user said that after a slow start she felt about “90% back to the ‘old me’” within a few months.
The tougher reviews: some Osphena users report hot flashes, weight gain, or cramps, or no improvement after three months. Many Intrarosa users find the discharge frustrating, and some don’t feel it did enough. A common thread for both: give it weeks, not days— relief from Intrarosa can take up to about three months.
Do the 2025–2026 FDA warning changes affect Osphena or Intrarosa?
On November 10, 2025, the FDA began removing broad boxed warnings (about heart disease, breast cancer, and probable dementia) from menopausal hormone therapy products. On February 12, 2026, it approved the first six relabeled products: Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva.
Neither Osphena nor Intrarosa was in that first group. As of June 2026, Osphena still carries its boxed warning— its own manufacturer site still shows it — and Intrarosa never had a boxed warning to begin with. Whether Osphena’s label changes down the road isn’t settled, and we re-check this every few months.
Can online menopause care help with Osphena or Intrarosa?
Online care can work well if your symptoms look like ordinary GSM, you have none of the red flags above, and you want a convenient way to talk to a clinician who treats menopause. Online care is the wrong first stepif you have unexplained bleeding, signs of an infection, a complicated cancer history, or anything urgent — those need an in-person exam.
How we pick providers (The HRT Index Verification Standard):
We read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a schedule (top providers monthly, the full roster quarterly). We judge on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access.
| Provider | What we verified (June 2026) | Model | Lists Osphena / Intrarosa? |
|---|---|---|---|
| Midi Health | GSM/sexual-wellness care, all 50 states, bills insurance, prescribes vaginal estradiol. Did not confirm it stocks Osphena or Intrarosa specifically — ask at intake. | Insurance-based | Not confirmed — ask first |
| Sesame | Sesame’s menopause service lists Ospemifene (Osphena) and DHEA inserts (Intrarosa) among its medication options. Medication cost is not included in the visit price. | Cash-pay (upfront) | Yes — both listed |
- Want care billed to insurance? Midi is a strong fit for GSM care and FDA-approved options. Because we couldn’t confirm it stocks these two specific drugs, ask at your visit.
- Specifically want to ask about Osphena or Intrarosa — or paying cash? Sesame’s menopause service lists both, and pricing is upfront. The medication itself is billed separately.
- Not sure which, or any red flag from the safety section? Start with Find My HRT Path — it points you to the right starting place, including when to be seen in person.
What to ask your clinician before you choose Osphena or Intrarosa
- Do my symptoms look like GSM, or do I need an exam or testing first?
- Is my main problem painful sex, vaginal dryness, or both?
- Do I have any bleeding that should be checked first?
- Does my breast-cancer history (mine or my family’s) change the safest option?
- Do my blood-clot, stroke, heart, or liver history affect whether Osphena is okay?
- Would low-dose vaginal estrogen be a cheaper option that fits me?
- Do I need a progesterone with this?
- How long should I try it before deciding it isn’t working?
- What side effects should make me stop and call you?
- What will this cost with my insurance or a coupon — and is there a prior-authorization step?
- Can I use lubricants or moisturizers along with it?
- If this one doesn’t fit, what’s the next option?
Turn these questions into a personalized plan you can bring to the right kind of clinician.
Get my pre-consult plan →How we verified this comparison
What we actually verified — June 2026:we read the current FDA labels (via DailyMed) for Osphena (ospemifene) and Intrarosa (prasterone) — the approved uses, dosing, warnings, contraindications, and common side effects. We checked both manufacturers’ savings pages and current pharmacy prices (GoodRx, SingleCare, Drugs.com) and confirmed neither has a generic. We confirmed Osphena still carries its boxed warning and Intrarosa has none, and we checked whether the 2025–2026 FDA warning changes apply to either (they don’t yet). We reviewed CADTH’s independent drug assessments and major menopause sources for treatment context, and we confirmed which medications Midi and Sesame publicly list.
| Type of claim | What we trust for it |
|---|---|
| FDA approval, warnings, dosing | The FDA label (DailyMed) |
| What’s first-line for GSM | The Menopause Society, major medical centers, peer-reviewed studies |
| Prices and savings | Manufacturer savings pages, pharmacy price pages, and your own plan |
| Day-to-day experience | Patient reviews and forums — for friction and language only |
| Our “best fit” calls | Always tied back to the verified facts above |
Osphena vs Intrarosa: FAQ
What’s the main difference between Osphena and Intrarosa?▼
Osphena is an oral pill (ospemifene, a SERM); Intrarosa is a nightly vaginal insert (prasterone, a form of DHEA). Both are FDA-approved prescriptions for painful sex from menopause, but Osphena is also approved for vaginal dryness.
Is Osphena estrogen?▼
No. Osphena is a SERM — a drug that acts like estrogen in some tissues and blocks it in others. It isn’t estrogen replacement, but it does have estrogen-like effects in some parts of the body.
Is Intrarosa estrogen?▼
No. Intrarosa is prasterone, a lab-made form of the hormone DHEA. It isn’t estrogen, but the body converts it into estrogens and androgens in the vaginal tissue.
Which is better for painful sex?▼
Both are FDA-approved for moderate-to-severe painful sex from menopause. An independent CADTH review found no evidence that either provides added benefit over other available treatments, and there is no head-to-head trial, so the better fit depends on how you’d rather take it, your health history, and cost.
Which is better for vaginal dryness?▼
Osphena has the clearer FDA label for vaginal dryness; it is approved for both dryness and painful sex. Intrarosa is approved for painful sex, though it can help dryness by improving the tissue.
How much do Osphena and Intrarosa cost without insurance in 2026?▼
Without insurance, Osphena runs about $85 for a 30-day supply (or $190 for 90) through its own programs. Intrarosa runs about $290–$420 a month — around $320 with a discount card — because its savings card is for insured or Medicare patients only. Confirm your price at the pharmacy.
Is there a generic for Osphena or Intrarosa?▼
No. As of June 2026, both are brand-name only, which keeps retail prices high.
Can I use Osphena or Intrarosa if I’ve had breast cancer?▼
Both labels steer breast-cancer survivors away, because each involves estrogen. Osphena’s label says not to use it with a breast-cancer history, and Intrarosa’s label says estrogen medicines aren’t for women who have or have had breast cancer. This is a decision to make with your clinician and oncologist, not from a web page.
Does Osphena cause hot flashes?▼
It can. Hot flashes are Osphena’s most commonly reported side effect because it works through the whole body. Intrarosa, acting locally, more often causes vaginal discharge instead.
Does Intrarosa cause discharge?▼
Yes. Vaginal discharge is the most common side effect on Intrarosa’s label, since it is inserted at night and some comes back out; with longer use, the label also notes changes on a Pap smear.
Can you use Osphena with vaginal estrogen?▼
Osphena’s label says not to use it with estrogens or similar drugs. Don’t combine GSM treatments unless your clinician specifically directs it.
Do I need a prescription for either one?▼
Yes. Both are prescription medications. Lubricants and over-the-counter moisturizers are not, but they don’t treat the underlying tissue change.
Is vaginal estrogen better than Osphena or Intrarosa?▼
Vaginal estrogen is the standard first-line option for GSM, it is often cheaper because several forms have generics, and very little estrogen reaches the bloodstream. The right choice depends on your history, your preference, and whether you want to avoid estrogen.
Still not sure which path is right for you?
Osphena and Intrarosa are both real, FDA-approved ways to treat painful sex after menopause — and you don’t have to keep guessing or quietly putting up with it. Take our free matching quiz — it takes about 90 seconds and gives you a personalized action plan to bring to your first consult.
Find My HRT Path →Related reading on The HRT Index
- Vaginal estrogen options compared
- Intrarosa vs Imvexxy: Cost & Safety (2026)
- Vagifem vs Imvexxy: Cost & Generic (2026)
- Osphena cost without insurance (2026)
- Intrarosa cost without insurance (2026)
Sources
FDA/DailyMed labels for Osphena (ospemifene) and Intrarosa (prasterone); Osphena savings page (Duchesnay USA) and Intrarosa savings pages (Millicent/Cosette); GoodRx, SingleCare, and Drugs.com pricing and patient reviews; FDA press announcements on menopausal hormone therapy labeling (Nov 10, 2025; Feb 12, 2026); CADTH reimbursement reviews of ospemifene and prasterone; The Menopause Society and major medical-center GSM guidance; Midi Health and Sesame public service pages. All verified June 2026.
The HRT Index is the independent menopause-HRT decision resource for women. This page is educational and not medical advice. FDA-approved and compounded options are always labeled separately, and compounded medications are never implied to be safer than, more natural than, or equal to FDA-approved medications.